NOVAI
Reading, GB · Founded 2020 · 7 known investors
Novai applies advanced molecular and computational approaches to eye disease, supporting clinicians and researchers in translating scientific findings into patient treatment options.
Founders & leadership
NOVAI was founded in 2020 by Prof. Francesca Cordeiro, Prof. M. Francesca Cordeiro, and MARIA FRANCESCA CORDEIRO.
PF
Prof. Francesca CordeiroFounder, Director & Chief Executive Officer
PM
Prof. M. Francesca CordeiroFounder & CEO
MF
MARIA FRANCESCA CORDEIROCo-founder
Board
NP
NATALIE PANKOVABoard director
KD
KARL DAVID KEEGANBoard director
SR
STEPHEN ROY PAGEBoard director
CM
CHRISTOPHER MARK WHEATCROFTBoard director
JH
JAMES HEDLEY RAWLINGSONBoard director
Investors · 7
Anglia Capital GroupNorwich
ExSight VenturesNew York
InBC Investment Corp.reportedBritish Columbia · $3M – $10M
ZincreportedLondonvia Natalie Pankova · board
Also in the syndicate · 3
Export Development CanadaleadGraham PartnersSeaspan
Funding
SEC filings, press & company announcements$1.1M disclosed across 1 of 2 rounds · 2023–2025
- Undisclosed amountSeries BMar 2025
Export Development Canada (lead), Graham Partners, InBC Investment Corp, Seaspan
Source ↗
▶$1.1MraisedMay 2023 · 22 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMay 2023 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- NATALIE PANKOVADirector
- STEPHEN ROY PAGEDirector
- MARIA FRANCESCA CORDEIRODirector
- KARL DAVID KEEGANDirector
- CHRISTOPHER MARK WHEATCROFTDirector
- JAMES HEDLEY RAWLINGSONDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- First sale
- Jan 2023
- Incorporated
- Other, United Kingdom, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Companies House · registry record
View on Companies House ↗- Registered name
- NOVAI LTD
- Company number
- 12457690
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 12 Feb 2020
- Registered office
- 9 Greyfriars Road, Reading, Berkshire, RG1 1NU
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 11 Mar 2026 · next due 25 Mar 2027
Current officers · 4
- Maria Francesca Cordeiro — director, appointed 12 Feb 2020
- Stephen Roy Page — director, appointed 28 Feb 2022
- Natalie Pankova — director, appointed 13 Dec 2020
- Christopher Mark Wheatcroft — director, appointed 28 Feb 2022
Source: Companies House public register · retrieved 30 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does NOVAI do?
- Novai applies advanced molecular and computational approaches to eye disease, supporting clinicians and researchers in translating scientific findings into patient treatment options.
- Who founded NOVAI?
- NOVAI was founded by Prof. Francesca Cordeiro, Prof. M. Francesca Cordeiro, MARIA FRANCESCA CORDEIRO in 2020.
- Who are NOVAI's investors?
- NOVAI's investors include Anglia Capital Group, ExSight Ventures, InBC Investment Corp., Zinc.
- How much funding has NOVAI raised?
- NOVAI has disclosed $1.1M raised across 1 of its 2 known rounds.
- Where is NOVAI headquartered?
- NOVAI is headquartered in Reading, GB.